The Annals Summaries of the Latest Medical Research!
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


The Annals of Pharmacotherapy: Vol. 31, No. 12, pp. 1507-1513.
© 1997 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ernst, M.
Right arrow Articles by Marangos, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ernst, M.
Right arrow Articles by Marangos, M.


Research Articles

Tetanus: pathophysiology and management

ME Ernst, ME Klepser, M Fouts, and MN Marangos

OBJECTIVE: To review the epidemiology, pathophysiology, clinical manifestations, diagnosis, and management of tetanus and its complications. DATA SOURCES: MEDLINE and Iowa Drug Information Services databases were searched for literature pertaining to tetanus. Additional literature was obtained from the references of selected articles identified in the search. Information from all articles was considered for inclusion in the manuscript. STUDY SELECTION AND DATA EXTRACTION: Articles selected were those considered by the authors to assist in providing the reader an understanding of the epidemiology, pathophysiology, clinical manifestations, diagnosis, and management of tetanus. DATA SYNTHESIS: While the number of tetanus cases has decreased markedly since data reporting for the disease began in 1947, mortality among those who acquire the disease remains high. Elderly patients are particularly susceptible to tetanus and its complications. Prevention of tetanus focuses on primary immunization and scheduled boosters. Management of tetanus involves initial stabilization of the patient and protection of the airway, prevention of tetanospasmin absorption by administration of human tetanus immune globulin 3000-6000 IU, and eradication of Clostridium tetani with antimicrobial therapy (metronidazole 500 mg q8h). Supportive measures include the administration of neuromuscular blocking agents such as pancuronium in patients requiring artificial ventilation, as well as benzodiazepines (midazolam 5-15 mg/h) for sedation and muscle relaxation. Autonomic dysfunction should be managed with beta-adrenergic blockers such as propranolol or labetalol. CONCLUSIONS: Despite the relative infrequency of tetanus cases, mortality among untreated patients remains significantly high. Clinicians should become knowledgeable in the pathophysiology, clinical manifestations, and management of this potentially fatal disease.


This article has been cited by other articles:


Home page
J Trop PediatrHome page
L. Guglani and R. Lodha
Enteral Baclofen in the Management of Tetanus-Related Spasms: Case Report and Review of Literature
J Trop Pediatr, April 1, 2007; 53(2): 139 - 141.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
T. J. Bunch, M. K. Thalji, P. A. Pellikka, and T. R. Aksamit
Respiratory Failure in Tetanus: Case Report and Review of a 25-Year Experience
Chest, October 1, 2002; 122(4): 1488 - 1492.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
J Kwan, S Lim, and S C Allen
Lessons from a case of tetanus in an elderly woman
Postgrad. Med. J., October 1, 1999; 75(888): 631 - 633.
[Full Text]




homecopy help contact us subscription past issues search current issue
Copyright © 1997 by Harvey Whitney Books Company.